3GXD - JenaLib

Asymmetric Unit (56, 56)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	TYR A:11 , SER A:12 , ARG A:353 , SER A:356 , TRP A:357 , ASP A:358	BINDING SITE FOR RESIDUE PO4 A 499
02	AC2	SOFTWARE	ARG A:44 , SER A:45 , HOH A:559	BINDING SITE FOR RESIDUE PO4 A 500
03	AC3	SOFTWARE	THR A:63 , GLY A:64 , GLN A:440 , HOH A:572 , LYS C:473	BINDING SITE FOR RESIDUE PO4 A 501
04	AC4	SOFTWARE	LYS A:79 , TRP A:228 , ARG A:277 , HIS A:306	BINDING SITE FOR RESIDUE PO4 A 502
05	AC5	SOFTWARE	LYS A:473 , THR C:63 , GLY C:64 , GLN C:440	BINDING SITE FOR RESIDUE PO4 A 503
06	AC6	SOFTWARE	ARG A:44 , SER A:465 , TYR A:487	BINDING SITE FOR RESIDUE PO4 A 498
07	AC7	SOFTWARE	THR A:272 , HIS A:273	BINDING SITE FOR RESIDUE PO4 A 504
08	AC8	SOFTWARE	HIS A:290 , LYS A:293 , HOH A:523 , HOH A:526	BINDING SITE FOR RESIDUE PO4 A 505
09	AC9	SOFTWARE	GLU A:254 , ARG A:257	BINDING SITE FOR RESIDUE PO4 A 506
10	BC1	SOFTWARE	ARG A:277 , HIS A:306 , HOH A:563	BINDING SITE FOR RESIDUE PO4 A 507
11	BC2	SOFTWARE	SER A:45 , ARG A:47	BINDING SITE FOR RESIDUE PO4 A 508
12	BC3	SOFTWARE	GLU A:72 , GLU D:254 , ARG D:257	BINDING SITE FOR RESIDUE PO4 A 509
13	BC4	SOFTWARE	ARG A:170 , PRO A:428	BINDING SITE FOR RESIDUE PO4 A 510
14	BC5	SOFTWARE	ARG A:395 , ASN D:392 , TRP D:393 , ARG D:395	BINDING SITE FOR RESIDUE PO4 A 511
15	BC6	SOFTWARE	THR A:187 , LYS A:198 , GLY A:199	BINDING SITE FOR RESIDUE PO4 A 512
16	BC7	SOFTWARE	ILE A:5 , ASN A:19 , THR A:21	BINDING SITE FOR RESIDUE NAG A 513
17	BC8	SOFTWARE	TYR A:11 , TRP A:348 , GLU A:349 , GLN A:350 , ARG A:353	BINDING SITE FOR RESIDUE PO4 A 514
18	BC9	SOFTWARE	TYR B:11 , SER B:12 , ARG B:353 , SER B:356 , TRP B:357 , ASP B:358	BINDING SITE FOR RESIDUE PO4 B 500
19	CC1	SOFTWARE	ARG B:44 , SER B:45	BINDING SITE FOR RESIDUE PO4 B 501
20	CC2	SOFTWARE	LYS B:79 , TRP B:228 , HIS B:306 , HOH B:534	BINDING SITE FOR RESIDUE PO4 B 502
21	CC3	SOFTWARE	GLY B:193 , LYS B:194 , SER B:242 , GLY B:243 , HOH B:524	BINDING SITE FOR RESIDUE PO4 B 503
22	CC4	SOFTWARE	LYS B:321 , ARG B:329 , ARG C:329 , LEU C:330	BINDING SITE FOR RESIDUE PO4 B 504
23	CC5	SOFTWARE	ARG B:44 , SER B:465 , TYR B:487	BINDING SITE FOR RESIDUE PO4 B 505
24	CC6	SOFTWARE	ARG B:277 , VAL B:305 , HIS B:306	BINDING SITE FOR RESIDUE PO4 B 498
25	CC7	SOFTWARE	ILE B:158 , PRO B:159 , HIS B:162	BINDING SITE FOR RESIDUE PO4 B 499
26	CC8	SOFTWARE	GLN B:226 , HIS B:273 , ASN B:275	BINDING SITE FOR RESIDUE PO4 B 506
27	CC9	SOFTWARE	ALA B:1 , ARG B:2 , SER B:25 , HOH B:518	BINDING SITE FOR RESIDUE PO4 B 507
28	DC1	SOFTWARE	ASN B:146 , HOH B:545 , HOH B:548 , LEU C:96	BINDING SITE FOR RESIDUE NAG B 508
29	DC2	SOFTWARE	ILE B:5 , ASN B:19	BINDING SITE FOR RESIDUE NAG B 509
30	DC3	SOFTWARE	LYS C:79 , TRP C:228 , ARG C:277 , HIS C:306	BINDING SITE FOR RESIDUE PO4 C 499
31	DC4	SOFTWARE	TYR C:11 , SER C:12 , ARG C:353 , SER C:356 , TRP C:357 , ASP C:358	BINDING SITE FOR RESIDUE PO4 C 500
32	DC5	SOFTWARE	ARG C:44 , SER C:45 , HOH C:552	BINDING SITE FOR RESIDUE PO4 C 501
33	DC6	SOFTWARE	ARG C:257 , HOH C:534 , HOH C:535	BINDING SITE FOR RESIDUE PO4 C 498
34	DC7	SOFTWARE	GLN C:226 , PHE C:227 , THR C:272 , HIS C:273 , VAL C:276	BINDING SITE FOR RESIDUE PO4 C 502
35	DC8	SOFTWARE	ARG C:44 , TYR C:487 , HOH C:556	BINDING SITE FOR RESIDUE PO4 C 503
36	DC9	SOFTWARE	ARG C:277 , HIS C:306 , HOH C:561	BINDING SITE FOR RESIDUE PO4 C 504
37	EC1	SOFTWARE	HIS C:290 , LYS C:293 , HOH C:523 , HOH C:562 , HOH C:569	BINDING SITE FOR RESIDUE PO4 C 505
38	EC2	SOFTWARE	ALA C:438 , ASN C:442 , HOH C:545 , HOH C:547	BINDING SITE FOR RESIDUE PO4 C 506
39	EC3	SOFTWARE	ILE C:158 , PRO C:159 , HIS C:162 , HOH C:516 , HOH C:559	BINDING SITE FOR RESIDUE PO4 C 507
40	EC4	SOFTWARE	PHE C:75 , HIS C:328 , HIS C:374	BINDING SITE FOR RESIDUE PO4 C 508
41	EC5	SOFTWARE	ARG C:170 , PRO C:428	BINDING SITE FOR RESIDUE PO4 C 509
42	EC6	SOFTWARE	ILE C:5 , ASN C:19 , THR C:21	BINDING SITE FOR RESIDUE NAG C 510
43	EC7	SOFTWARE	TYR C:11 , TRP C:348 , GLU C:349 , GLN C:350 , ARG C:353	BINDING SITE FOR RESIDUE PO4 C 511
44	EC8	SOFTWARE	TYR D:11 , SER D:12 , ARG D:353 , SER D:356 , TRP D:357 , ASP D:358	BINDING SITE FOR RESIDUE PO4 D 499
45	EC9	SOFTWARE	ARG D:44 , SER D:45	BINDING SITE FOR RESIDUE PO4 D 500
46	FC1	SOFTWARE	LYS D:79 , TRP D:228 , ARG D:277 , HIS D:306 , HOH D:560	BINDING SITE FOR RESIDUE PO4 D 501
47	FC2	SOFTWARE	GLY D:193 , LYS D:194 , SER D:242 , GLY D:243 , HOH D:531	BINDING SITE FOR RESIDUE PO4 D 502
48	FC3	SOFTWARE	GLN D:226 , HIS D:273 , ASN D:275	BINDING SITE FOR RESIDUE PO4 D 498
49	FC4	SOFTWARE	ARG D:44 , TYR D:487	BINDING SITE FOR RESIDUE PO4 D 503
50	FC5	SOFTWARE	ARG D:277 , VAL D:305 , HIS D:306 , HOH D:554	BINDING SITE FOR RESIDUE PO4 D 504
51	FC6	SOFTWARE	ILE D:158 , PRO D:159 , HIS D:162 , HOH D:541	BINDING SITE FOR RESIDUE PO4 D 505
52	FC7	SOFTWARE	ARG D:262	BINDING SITE FOR RESIDUE PO4 D 506
53	FC8	SOFTWARE	ARG A:329 , LYS D:321 , ARG D:329	BINDING SITE FOR RESIDUE PO4 D 507
54	FC9	SOFTWARE	THR D:187 , LYS D:198 , GLY D:199 , HOH D:533 , HOH D:542	BINDING SITE FOR RESIDUE PO4 D 508
55	GC1	SOFTWARE	LEU A:96 , ASN D:146 , HOH D:517 , HOH D:545	BINDING SITE FOR RESIDUE NAG D 509
56	GC2	SOFTWARE	ASN D:19 , TYR D:22 , HOH D:561	BINDING SITE FOR RESIDUE NAG D 510

SS Bonds (8, 8)

Cis Peptide Bonds (14, 14)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (156, 624)

Asymmetric/Biological Unit (156, 624)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_063066	K	46	E	GLCM_HUMAN	Polymorphism	142761046	A/B/C/D	K	7	E
002	UniProt	VAR_003255	V	54	L	GLCM_HUMAN	Disease (GD)	121908302	A/B/C/D	V	15	L
003	UniProt	VAR_032394	C	55	S	GLCM_HUMAN	Disease (GD)	773007510	A/B/C/D	C	16	S
004	UniProt	VAR_032395	D	63	N	GLCM_HUMAN	Disease (GD1)	---	A/B/C/D	D	24	N
005	UniProt	VAR_003256	F	76	V	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	F	37	V
006	UniProt	VAR_009033	E	80	K	GLCM_HUMAN	Disease (GD2)	1141808	A/B/C/D	E	41	K
007	UniProt	VAR_003257	T	82	I	GLCM_HUMAN	Disease (GD)	1141811	A/B/C/D	T	43	I
008	UniProt	VAR_003258	G	85	E	GLCM_HUMAN	Disease (GD)	77829017	A/B/C/D	G	46	E
009	UniProt	VAR_032197	R	87	Q	GLCM_HUMAN	Disease (GD)	78769774	A/B/C/D	R	48	Q
010	UniProt	VAR_003259	R	87	W	GLCM_HUMAN	Disease (GD)	1141814	A/B/C/D	R	48	W
011	UniProt	VAR_032396	M	92	T	GLCM_HUMAN	Polymorphism	3205619	A/B/C/D	M	53	T
012	UniProt	VAR_003260	K	118	N	GLCM_HUMAN	Disease (GD)	121908312	A/B/C/D	K	79	N
013	UniProt	VAR_032397	A	129	T	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	A	90	T
014	UniProt	VAR_009034	S	146	L	GLCM_HUMAN	Disease (GD)	758447515	A/B/C/D	S	107	L
015	UniProt	VAR_003261	G	152	E	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	G	113	E
016	UniProt	VAR_032398	N	156	D	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	N	117	D
017	UniProt	VAR_032399	I	158	S	GLCM_HUMAN	Disease (GD1)	77834747	A/B/C/D	I	119	S
018	UniProt	VAR_003262	I	158	T	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	I	119	T
019	UniProt	VAR_003263	R	159	Q	GLCM_HUMAN	Disease (GD)	79653797	A/B/C/D	R	120	Q
020	UniProt	VAR_003264	R	159	W	GLCM_HUMAN	Disease (GD)	397515515	A/B/C/D	R	120	W
021	UniProt	VAR_032198	P	161	L	GLCM_HUMAN	Disease (GD)	79637617	A/B/C/D	P	122	L
022	UniProt	VAR_003265	P	161	S	GLCM_HUMAN	Disease (GD)	121908299	A/B/C/D	P	122	S
023	UniProt	VAR_032199	M	162	V	GLCM_HUMAN	Disease (GD)	377325220	A/B/C/D	M	123	V
024	UniProt	VAR_032200	D	166	V	GLCM_HUMAN	Disease (GD)	79796061	A/B/C/D	D	127	V
025	UniProt	VAR_009035	R	170	C	GLCM_HUMAN	Disease (GD2)	398123530	A/B/C/D	R	131	C
026	UniProt	VAR_009036	R	170	L	GLCM_HUMAN	Disease (GD)	80356763	A/B/C/D	R	131	L
027	UniProt	VAR_032400	T	173	I	GLCM_HUMAN	Disease (GD)	78657146	A/B/C/D	T	134	I
028	UniProt	VAR_003266	T	173	P	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	T	134	P
029	UniProt	VAR_032401	A	175	E	GLCM_HUMAN	Disease (GD)	79660787	A/B/C/D	A	136	E
030	UniProt	VAR_003267	D	179	H	GLCM_HUMAN	Disease (GD)	147138516	A/B/C/D	D	140	H
031	UniProt	VAR_003268	K	196	Q	GLCM_HUMAN	Disease (GD)	121908297	A/B/C/D	K	157	Q
032	UniProt	VAR_009037	P	198	L	GLCM_HUMAN	Disease (GD)	80222298	A/B/C/D	P	159	L
033	UniProt	VAR_032402	P	198	T	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	P	159	T
034	UniProt	VAR_032201	I	200	N	GLCM_HUMAN	Disease (GD)	77933015	A/B/C/D	I	161	N
035	UniProt	VAR_010059	I	200	S	GLCM_HUMAN	Disease (GD)	77933015	A/B/C/D	I	161	S
036	UniProt	VAR_032403	H	201	P	GLCM_HUMAN	Disease (GD)	76500263	A/B/C/D	H	162	P
037	UniProt	VAR_032404	R	209	C	GLCM_HUMAN	Disease (GD)	398123532	A/B/C/D	R	170	C
038	UniProt	VAR_003269	R	209	P	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	R	170	P
039	UniProt	VAR_032202	L	213	F	GLCM_HUMAN	Disease (GD)	374591570	A/B/C/D	L	174	F
040	UniProt	VAR_003270	A	215	D	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	A	176	D
041	UniProt	VAR_003271	P	217	S	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	P	178	S
042	UniProt	VAR_032405	P	221	L	GLCM_HUMAN	Disease (GD1)	80205046	A/B/C/D	P	182	L
043	UniProt	VAR_003272	P	221	T	GLCM_HUMAN	Disease (GD)	866075757	A/B/C/D	P	182	T
044	UniProt	VAR_003273	W	223	R	GLCM_HUMAN	Disease (GD)	61748906	A/B/C/D	W	184	R
045	UniProt	VAR_032203	L	224	F	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	L	185	F
046	UniProt	VAR_003275	N	227	K	GLCM_HUMAN	Disease (GD)	381418	A/B/C/D	N	188	K
047	UniProt	VAR_003274	N	227	S	GLCM_HUMAN	Disease (GD)	364897	A/B/C/D	N	188	S
048	UniProt	VAR_010060	G	228	V	GLCM_HUMAN	Disease (GD)	78911246	A/B/C/D	G	189	V
049	UniProt	VAR_009038	A	229	E	GLCM_HUMAN	Disease (GD)	75636769	A/B/C/D	A	190	E
050	UniProt	VAR_032406	A	229	T	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	A	190	T
051	UniProt	VAR_032407	V	230	E	GLCM_HUMAN	Disease (GD1)	381427	A/B/C/D	V	191	E
052	UniProt	VAR_003276	V	230	G	GLCM_HUMAN	Disease (GD1)	381427	A/B/C/D	V	191	G
053	UniProt	VAR_032204	G	232	E	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	G	193	E
054	UniProt	VAR_003277	G	234	E	GLCM_HUMAN	Disease (GD)	74462743	A/B/C/D	G	195	E
055	UniProt	VAR_009039	G	234	W	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	G	195	W
056	UniProt	VAR_003278	S	235	P	GLCM_HUMAN	Disease (GD)	1064644	A/B/C/D	S	196	P
057	UniProt	VAR_032205	K	237	E	GLCM_HUMAN	Disease (GD)	773409311	A/B/C/D	K	198	E
058	UniProt	VAR_010061	G	241	E	GLCM_HUMAN	Disease (GD)	77451368	A/B/C/D	G	202	E
059	UniProt	VAR_003279	G	241	R	GLCM_HUMAN	Disease (GD)	398123534	A/B/C/D	G	202	R
060	UniProt	VAR_010062	Y	244	C	GLCM_HUMAN	Disease (GD)	76026102	A/B/C/D	Y	205	C
061	UniProt	VAR_003280	Y	251	H	GLCM_HUMAN	Disease (GD)	121908300	A/B/C/D	Y	212	H
062	UniProt	VAR_003281	F	252	I	GLCM_HUMAN	Disease (GD)	381737	A/B/C/D	F	213	I
063	UniProt	VAR_003282	F	255	Y	GLCM_HUMAN	Disease (GD)	74500255	A/B/C/D	F	216	Y
064	UniProt	VAR_032408	T	270	R	GLCM_HUMAN	Disease (GD)	76725886	A/B/C/D	T	231	R
065	UniProt	VAR_003283	S	276	P	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	S	237	P
066	UniProt	VAR_032409	F	290	L	GLCM_HUMAN	Disease (GD)	121908313	A/B/C/D	F	251	L
067	UniProt	VAR_009040	H	294	Q	GLCM_HUMAN	Disease (GD1)	367968666	A/B/C/D	H	255	Q
068	UniProt	VAR_003284	R	296	Q	GLCM_HUMAN	Disease (GD)	78973108	A/B/C/D	R	257	Q
069	UniProt	VAR_009041	F	298	L	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	F	259	L
070	UniProt	VAR_032206	L	303	I	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	L	264	I
071	UniProt	VAR_010063	G	304	D	GLCM_HUMAN	Disease (GD)	80116658	A/B/C/D	G	265	D
072	UniProt	VAR_003285	P	305	R	GLCM_HUMAN	Disease (GD)	79215220	A/B/C/D	P	266	R
073	UniProt	VAR_032410	S	310	G	GLCM_HUMAN	Polymorphism	1057942	A/B/C/D	S	271	G
074	UniProt	VAR_010064	S	310	N	GLCM_HUMAN	Disease (GD)	74731340	A/B/C/D	S	271	N
075	UniProt	VAR_003286	R	324	C	GLCM_HUMAN	Disease (GD)	765633380	A/B/C/D	R	285	C
076	UniProt	VAR_009042	R	324	H	GLCM_HUMAN	Disease (GD)	79696831	A/B/C/D	R	285	H
077	UniProt	VAR_003287	P	328	L	GLCM_HUMAN	Disease (GD)	121908298	A/B/C/D	P	289	L
078	UniProt	VAR_003288	K	342	I	GLCM_HUMAN	Disease (GD)	77714449	A/B/C/D	K	303	I
079	UniProt	VAR_009043	Y	343	C	GLCM_HUMAN	Disease (GD)	77321207	A/B/C/D	Y	304	C
080	UniProt	VAR_003289	A	348	V	GLCM_HUMAN	Disease (GD)	78396650	A/B/C/D	A	309	V
081	UniProt	VAR_009044	H	350	R	GLCM_HUMAN	Polymorphism	78198234	A/B/C/D	H	311	R
082	UniProt	VAR_003290	W	351	C	GLCM_HUMAN	Disease (GD)	121908304	A/B/C/D	W	312	C
083	UniProt	VAR_003291	Y	352	H	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	Y	313	H
084	UniProt	VAR_003292	D	354	H	GLCM_HUMAN	Disease (GD)	398123526	A/B/C/D	D	315	H
085	UniProt	VAR_003293	A	357	D	GLCM_HUMAN	Disease (GD)	78188205	A/B/C/D	A	318	D
086	UniProt	VAR_003294	T	362	I	GLCM_HUMAN	Disease (GD)	76539814	A/B/C/D	T	323	I
087	UniProt	VAR_003295	L	363	P	GLCM_HUMAN	Unclassified (GD)	---	A/B/C/D	L	324	P
088	UniProt	VAR_003296	G	364	R	GLCM_HUMAN	Disease (GD)	121908305	A/B/C/D	G	325	R
089	UniProt	VAR_003297	E	365	K	GLCM_HUMAN	Disease (GD)	2230288	A/B/C/D	E	326	K
090	UniProt	VAR_032411	R	368	H	GLCM_HUMAN	Polymorphism	1064648	A/B/C/D	R	329	H
091	UniProt	VAR_009045	A	380	T	GLCM_HUMAN	Disease (GD)	781306264	A/B/C/D	A	341	T
092	UniProt	VAR_003298	C	381	G	GLCM_HUMAN	Disease (GD)	121908306	A/B/C/D	C	342	G
093	UniProt	VAR_032207	E	388	K	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	E	349	K
094	UniProt	VAR_010065	V	391	L	GLCM_HUMAN	Disease (GD)	398123527	A/B/C/D	V	352	L
095	UniProt	VAR_010066	R	392	G	GLCM_HUMAN	Disease (GD)	121908308	A/B/C/D	R	353	G
096	UniProt	VAR_032208	R	392	W	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	R	353	W
097	UniProt	VAR_003299	R	398	Q	GLCM_HUMAN	Disease (GD)	74979486	A/B/C/D	R	359	Q
098	UniProt	VAR_032412	M	400	I	GLCM_HUMAN	Disease (GD)	149487315	A/B/C/D	M	361	I
099	UniProt	VAR_032209	Y	402	C	GLCM_HUMAN	Disease (GD)	76228122	A/B/C/D	Y	363	C
100	UniProt	VAR_003300	S	403	T	GLCM_HUMAN	Disease (GD)	121908307	A/B/C/D	S	364	T
101	UniProt	VAR_010067	S	405	G	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	S	366	G
102	UniProt	VAR_009046	S	405	N	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	S	366	N
103	UniProt	VAR_003301	T	408	M	GLCM_HUMAN	Disease (GD)	2230289	A/B/C/D	T	369	M
104	UniProt	VAR_003302	N	409	S	GLCM_HUMAN	Disease (GD1)	76763715	A/B/C/D	N	370	S
105	UniProt	VAR_032210	L	410	V	GLCM_HUMAN	Disease (GD)	121908314	A/B/C/D	L	371	V
106	UniProt	VAR_010068	V	414	L	GLCM_HUMAN	Disease (GD)	398123528	A/B/C/D	V	375	L
107	UniProt	VAR_003303	G	416	S	GLCM_HUMAN	Disease (GD)	121908311	A/B/C/D	G	377	S
108	UniProt	VAR_003304	W	417	G	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	W	378	G
109	UniProt	VAR_003305	D	419	A	GLCM_HUMAN	Disease (GD)	77284004	A/B/C/D	D	380	A
110	UniProt	VAR_032211	D	419	H	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	D	380	H
111	UniProt	VAR_003306	D	419	N	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	D	380	N
112	UniProt	VAR_032212	N	421	K	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	N	382	K
113	UniProt	VAR_010069	P	426	L	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	P	387	L
114	UniProt	VAR_003307	G	428	E	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	G	389	E
115	UniProt	VAR_032213	G	429	R	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	G	390	R
116	UniProt	VAR_003308	P	430	L	GLCM_HUMAN	Disease (GD)	76910485	A/B/C/D	P	391	L
117	UniProt	VAR_003309	N	431	I	GLCM_HUMAN	Disease (GD)	77738682	A/B/C/D	N	392	I
118	UniProt	VAR_009047	W	432	R	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	W	393	R
119	UniProt	VAR_003310	V	433	L	GLCM_HUMAN	Disease (GD)	80356769	A/B/C/D	V	394	L
120	UniProt	VAR_003311	N	435	T	GLCM_HUMAN	Disease (GD1)	75385858	A/B/C/D	N	396	T
121	UniProt	VAR_032214	F	436	S	GLCM_HUMAN	Disease (GD)	75243000	A/B/C/D	F	397	S
122	UniProt	VAR_009048	V	437	F	GLCM_HUMAN	Polymorphism	121908310	A/B/C/D	V	398	F
123	UniProt	VAR_010070	V	437	L	GLCM_HUMAN	Disease (GD3)	---	A/B/C/D	V	398	L
124	UniProt	VAR_003312	D	438	N	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	D	399	N
125	UniProt	VAR_032413	D	438	Y	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	D	399	Y
126	UniProt	VAR_010071	P	440	L	GLCM_HUMAN	Disease (GD1)	74598136	A/B/C/D	P	401	L
127	UniProt	VAR_032414	I	441	F	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	I	402	F
128	UniProt	VAR_010072	I	441	T	GLCM_HUMAN	Disease (GD)	75564605	A/B/C/D	I	402	T
129	UniProt	VAR_003313	D	448	H	GLCM_HUMAN	Disease (GD)	1064651	A/B/C/D	D	409	H
130	UniProt	VAR_003314	D	448	V	GLCM_HUMAN	Disease (GD)	77369218	A/B/C/D	D	409	V
131	UniProt	VAR_010073	F	450	I	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	F	411	I
132	UniProt	VAR_003315	Y	451	H	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	Y	412	H
133	UniProt	VAR_010074	K	452	Q	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	K	413	Q
134	UniProt	VAR_003316	P	454	R	GLCM_HUMAN	Disease (GD)	121908295	A/B/C/D	P	415	R
135	UniProt	VAR_032215	M	455	V	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	M	416	V
136	UniProt	VAR_003317	F	456	V	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	F	417	V
137	UniProt	VAR_003318	Y	457	C	GLCM_HUMAN	Disease (GD)	74752878	A/B/C/D	Y	418	C
138	UniProt	VAR_032415	G	460	D	GLCM_HUMAN	Disease (GD1)	---	A/B/C/D	G	421	D
139	UniProt	VAR_003319	K	464	E	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	K	425	E
140	UniProt	VAR_063067	D	482	N	GLCM_HUMAN	Polymorphism	75671029	A/B/C/D	D	443	N
141	UniProt	VAR_003321	L	483	P	GLCM_HUMAN	Disease (GD2)	421016	A/B/C/D	L	444	P
142	UniProt	VAR_003320	L	483	R	GLCM_HUMAN	Disease (GD)	421016	A/B/C/D	L	444	R
143	UniProt	VAR_003322	A	485	P	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	A	446	P
144	UniProt	VAR_032416	H	490	R	GLCM_HUMAN	Disease (GD)	76071730	A/B/C/D	H	451	R
145	UniProt	VAR_003323	A	495	P	GLCM_HUMAN	Disease (GD)	368060	A/B/C/D	A	456	P
146	UniProt	VAR_063068	V	497	L	GLCM_HUMAN	Polymorphism	---	A/B/C/D	V	458	L
147	UniProt	VAR_032216	L	500	P	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	L	461	P
148	UniProt	VAR_009049	N	501	K	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	N	462	K
149	UniProt	VAR_003324	R	502	C	GLCM_HUMAN	Disease (GD)	80356771	A/B/C/D	R	463	C
150	UniProt	VAR_032217	R	502	P	GLCM_HUMAN	Disease (GD)	---	A/B/C/D	R	463	P
151	UniProt	VAR_003325	L	509	P	GLCM_HUMAN	Polymorphism	---	A/B/C/D	L	470	P
152	UniProt	VAR_009050	D	513	Y	GLCM_HUMAN	Disease (GD2)	---	A/B/C/D	D	474	Y
153	UniProt	VAR_003326	G	517	S	GLCM_HUMAN	Disease (GD)	121908301	A/B/C/D	G	478	S
154	UniProt	VAR_010075	T	530	I	GLCM_HUMAN	Disease (GD3)	78016673	A/B/C/D	T	491	I
155	UniProt	VAR_003327	R	535	C	GLCM_HUMAN	Disease (GD)	747506979	A/B/C/D	R	496	C
156	UniProt	VAR_003328	R	535	H	GLCM_HUMAN	Disease (GD)	75822236	A/B/C/D	R	496	H

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

PROSITE Motifs (0, 0)

Exons (9, 36)

Sequences/Alignments

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:497
 aligned with GLCM_HUMAN | P04062 from UniProtKB/Swiss-Prot  Length:536

    Alignment length:497
                                    49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429       439       449       459       469       479       489       499       509       519       529       
           GLCM_HUMAN    40 ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ 536
               SCOP domains d3gxda1 A:1-77,A:432-497 Glucosylceramidase                                  d3gxda2 A:78-431 Glucosylceramidase, catalytic domain                                                                                                                                                                                                                                                                                                             d3gxda1 A:1-77,A:432-497 Glucosylceramidase                        SCOP domains
               CATH domains ----3gxdA01 A:5-30,A:78-431   ----3gxdA02 A:35-77,A:432-497                  3gxdA01 A:5-30,A:78-431 Glycosidases                                                                                                                                                                                                                                                                                                                              3gxdA02 A:35-77,A:432-497 Golgi alpha-mannosidase II               CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....ee.......eeee.................eeeeeeee......eeeeee.........eeeeeeeeeeeee..eeeee.hhhhhhhhhh.hhhhhhhhhhhhhh.......eeeeee..........................hhhhhhhhhhhhhhhhhhh....eeeeee...hhhhh................hhhhhhhhhhhhhhhhhhhhh.....eee...hhhhhhh..........hhhhhhhhhhhhhhhhhhh......eeeeeeee.hhhhhhhhhhhhhhhhhh...eeeeee..........hhhhhhhhh...eeeeeee..............hhhhhhhhhhhhhhhhhh.eeeeeeee...................eeeehhhheeeehhhhhhhhhhhh......eeeeeee......eeeeee.....eeeeeee.....eeeeeee...eeeeeee...eeeeeee... Sec.struct. author
             SAPs(SNPs) (1) ------E-------LS-------N------------V---K-I--E-Q----T-------------------------N----------T----------------L-----E---D-SQ-LV---V---C--I-E---H----------------Q-L-NP-------C---F-D-S---L-RF--KVEE-E-EP-E---E--C------HI--Y--------------R-----P-------------L---Q-Q-L----IDR----G-------------C---L-------------IC----V-RCH-H--D----IPRK--H-----------TG------K--LG-----Q-I-CT-G--MSV---L-SG-A-K----L-ERLIRL-TSFN-LF------H-IHQ-RVVC--D---E-----------------NP-P----R----P-L--PKC------P---Y---S------------I----C- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -----------------------------------------------W----------------------------------------------------------------------TW-S--------L--P------------------------T-S--------P-----------T-----S-TG---W------R--------------------------------------------------------------------N-------------H-------------------------------------------------------------------W------------N-------------H-----------------LY--T------V----------------------------------R------------------P--------------------------------H- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------N--------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.6c  PDB: A:1-64 UniProt: 39-103 [INCOMPLETE]             ------------------------------------------------Exon 1.8e  PDB: A:113-157 UniProt: 152-196   ---------------------------------------------------------Exon 1.10  PDB: A:215-294 UniProt: 254-333                                      Exon 1.11b  PDB: A:295-369 UniProt: 334-408                                Exon 1.12a  PDB: A:370-424 UniProt: 409-463            --------------------------------------Exon 1.13d  PDB: A:463-497          Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------Exon 1.7b  PDB: A:64-113 UniProt: 103-152         --------------------------------------------Exon 1.9b  PDB: A:158-215 UniProt: 197-254                ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.12d  PDB: A:424-463              ---------------------------------- Transcript 1 (2)
                 3gxd A   1 ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ 497
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490

Chain B from PDB  Type:PROTEIN  Length:497
 aligned with GLCM_HUMAN | P04062 from UniProtKB/Swiss-Prot  Length:536

    Alignment length:497
                                    49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429       439       449       459       469       479       489       499       509       519       529       
           GLCM_HUMAN    40 ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ 536
               SCOP domains d3gxdb1 B:1-77,B:432-497 Glucosylceramidase                                  d3gxdb2 B:78-431 Glucosylceramidase, catalytic domain                                                                                                                                                                                                                                                                                                             d3gxdb1 B:1-77,B:432-497 Glucosylceramidase                        SCOP domains
               CATH domains ----3gxdB01 B:5-30,B:78-431   ----3gxdB02 B:35-77,B:432-497                  3gxdB01 B:5-30,B:78-431 Glycosidases                                                                                                                                                                                                                                                                                                                              3gxdB02 B:35-77,B:432-497 Golgi alpha-mannosidase II               CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....ee.......eeee.................eeeeeeee......eeeeee.........eeeeeeeeeeeee..eeeee.hhhhhhhhhh.hhhhhhhhhhhhhh.......eeeeee..........................hhhhhhhhhhhhhhhhhhh....eeeeee...hhhhh................hhhhhhhhhhhhhhhhhhhh......eee...hhhhhhh..........hhhhhhhhhhhhhhhhhhhh.....eeeeeeee.hhhhhhhhhhhhhhhhhh...eeeeeee.........hhhhhhhhh...eeeeeeee.............hhhhhhhhhhhhhhhhhh...eeeeee...................eeeehhhheeeehhhhhhhhhhhh......eeeeeee......eeeeee.....eeeeeee.....eeeeeee...eeeeeee...eeeeeee... Sec.struct. author
             SAPs(SNPs) (1) ------E-------LS-------N------------V---K-I--E-Q----T-------------------------N----------T----------------L-----E---D-SQ-LV---V---C--I-E---H----------------Q-L-NP-------C---F-D-S---L-RF--KVEE-E-EP-E---E--C------HI--Y--------------R-----P-------------L---Q-Q-L----IDR----G-------------C---L-------------IC----V-RCH-H--D----IPRK--H-----------TG------K--LG-----Q-I-CT-G--MSV---L-SG-A-K----L-ERLIRL-TSFN-LF------H-IHQ-RVVC--D---E-----------------NP-P----R----P-L--PKC------P---Y---S------------I----C- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -----------------------------------------------W----------------------------------------------------------------------TW-S--------L--P------------------------T-S--------P-----------T-----S-TG---W------R--------------------------------------------------------------------N-------------H-------------------------------------------------------------------W------------N-------------H-----------------LY--T------V----------------------------------R------------------P--------------------------------H- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------N--------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.6c  PDB: B:1-64 UniProt: 39-103 [INCOMPLETE]             ------------------------------------------------Exon 1.8e  PDB: B:113-157 UniProt: 152-196   ---------------------------------------------------------Exon 1.10  PDB: B:215-294 UniProt: 254-333                                      Exon 1.11b  PDB: B:295-369 UniProt: 334-408                                Exon 1.12a  PDB: B:370-424 UniProt: 409-463            --------------------------------------Exon 1.13d  PDB: B:463-497          Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------Exon 1.7b  PDB: B:64-113 UniProt: 103-152         --------------------------------------------Exon 1.9b  PDB: B:158-215 UniProt: 197-254                ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.12d  PDB: B:424-463              ---------------------------------- Transcript 1 (2)
                 3gxd B   1 ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ 497
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490

Chain C from PDB  Type:PROTEIN  Length:497
 aligned with GLCM_HUMAN | P04062 from UniProtKB/Swiss-Prot  Length:536

    Alignment length:497
                                    49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429       439       449       459       469       479       489       499       509       519       529       
           GLCM_HUMAN    40 ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ 536
               SCOP domains d3gxdc1 C:1-77,C:432-497 Glucosylceramidase                                  d3gxdc2 C:78-431 Glucosylceramidase, catalytic domain                                                                                                                                                                                                                                                                                                             d3gxdc1 C:1-77,C:432-497 Glucosylceramidase                        SCOP domains
               CATH domains ----3gxdC01 C:5-30,C:78-431   ----3gxdC02 C:35-77,C:432-497                  3gxdC01 C:5-30,C:78-431 Glycosidases                                                                                                                                                                                                                                                                                                                              3gxdC02 C:35-77,C:432-497 Golgi alpha-mannosidase II               CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....ee.......eeee.................eeeeeeee......eeeeee.........eeeeeeeeeeeee..eeeee.hhhhhhhhh..hhhhhhhhhhhhhh.......eeeeee..........................hhhhhhhhhhhhhhhhhhh....eeeeee...hhhhh................hhhhhhhhhhhhhhhhhhhhh.....eee.....hhhhh..........hhhhhhhhhhhhhhhhhhh......eeeeeeee.hhhhhhhhhhhhhhhhhh.eeeeeee.......hhhhhhhhhhhhh...eeeeeee..............hhhhhhhhhhhhhhhhhh.eeeeeeee...................eeeehhhheeeehhhhhhhhhhhh......eeeeeee......eeeeee.....eeeeeee.....eeeeeee...eeeeeee...eeeeeee... Sec.struct. author
             SAPs(SNPs) (1) ------E-------LS-------N------------V---K-I--E-Q----T-------------------------N----------T----------------L-----E---D-SQ-LV---V---C--I-E---H----------------Q-L-NP-------C---F-D-S---L-RF--KVEE-E-EP-E---E--C------HI--Y--------------R-----P-------------L---Q-Q-L----IDR----G-------------C---L-------------IC----V-RCH-H--D----IPRK--H-----------TG------K--LG-----Q-I-CT-G--MSV---L-SG-A-K----L-ERLIRL-TSFN-LF------H-IHQ-RVVC--D---E-----------------NP-P----R----P-L--PKC------P---Y---S------------I----C- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -----------------------------------------------W----------------------------------------------------------------------TW-S--------L--P------------------------T-S--------P-----------T-----S-TG---W------R--------------------------------------------------------------------N-------------H-------------------------------------------------------------------W------------N-------------H-----------------LY--T------V----------------------------------R------------------P--------------------------------H- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------N--------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.6c  PDB: C:1-64 UniProt: 39-103 [INCOMPLETE]             ------------------------------------------------Exon 1.8e  PDB: C:113-157 UniProt: 152-196   ---------------------------------------------------------Exon 1.10  PDB: C:215-294 UniProt: 254-333                                      Exon 1.11b  PDB: C:295-369 UniProt: 334-408                                Exon 1.12a  PDB: C:370-424 UniProt: 409-463            --------------------------------------Exon 1.13d  PDB: C:463-497          Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------Exon 1.7b  PDB: C:64-113 UniProt: 103-152         --------------------------------------------Exon 1.9b  PDB: C:158-215 UniProt: 197-254                ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.12d  PDB: C:424-463              ---------------------------------- Transcript 1 (2)
                 3gxd C   1 ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ 497
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490

Chain D from PDB  Type:PROTEIN  Length:497
 aligned with GLCM_HUMAN | P04062 from UniProtKB/Swiss-Prot  Length:536

    Alignment length:497
                                    49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429       439       449       459       469       479       489       499       509       519       529       
           GLCM_HUMAN    40 ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ 536
               SCOP domains d3gxdd1 D:1-77,D:432-497 Glucosylceramidase                                  d3gxdd2 D:78-431 Glucosylceramidase, catalytic domain                                                                                                                                                                                                                                                                                                             d3gxdd1 D:1-77,D:432-497 Glucosylceramidase                        SCOP domains
               CATH domains ----3gxdD01 D:5-30,D:78-431   ----3gxdD02 D:35-77,D:432-497                  3gxdD01 D:5-30,D:78-431 Glycosidases                                                                                                                                                                                                                                                                                                                              3gxdD02 D:35-77,D:432-497 Golgi alpha-mannosidase II               CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....ee.......eeee.................eeeeeeee....eeeeeeeeee.......eeeeeeeeeeeee..eeeee.hhhhhhhhhh.hhhhhhhhhhhhhh.......eeeeee..........................hhhhhhhhhhhhhhhhhhh....eeeeee...hhhhh................hhhhhhhhhhhhhhhhhhhhh.....eee.....hhhhh..........hhhhhhhhhhhhhhhhhhhh.....eeeeeeee.hhhhhhhhhhhhhhhhhh...eeeeeee.........hhhhhhhhh...eeeeeeee.............hhhhhhhhhhhhhhhhhh.eeeeeeee...................eeeehhhheeeehhhhhhhhhhhh......eeeeeee......eeeeee.....eeeeeee.....eeeeeee...eeeeeee...eeeeeee... Sec.struct. author
             SAPs(SNPs) (1) ------E-------LS-------N------------V---K-I--E-Q----T-------------------------N----------T----------------L-----E---D-SQ-LV---V---C--I-E---H----------------Q-L-NP-------C---F-D-S---L-RF--KVEE-E-EP-E---E--C------HI--Y--------------R-----P-------------L---Q-Q-L----IDR----G-------------C---L-------------IC----V-RCH-H--D----IPRK--H-----------TG------K--LG-----Q-I-CT-G--MSV---L-SG-A-K----L-ERLIRL-TSFN-LF------H-IHQ-RVVC--D---E-----------------NP-P----R----P-L--PKC------P---Y---S------------I----C- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -----------------------------------------------W----------------------------------------------------------------------TW-S--------L--P------------------------T-S--------P-----------T-----S-TG---W------R--------------------------------------------------------------------N-------------H-------------------------------------------------------------------W------------N-------------H-----------------LY--T------V----------------------------------R------------------P--------------------------------H- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------N--------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.6c  PDB: D:1-64 UniProt: 39-103 [INCOMPLETE]             ------------------------------------------------Exon 1.8e  PDB: D:113-157 UniProt: 152-196   ---------------------------------------------------------Exon 1.10  PDB: D:215-294 UniProt: 254-333                                      Exon 1.11b  PDB: D:295-369 UniProt: 334-408                                Exon 1.12a  PDB: D:370-424 UniProt: 409-463            --------------------------------------Exon 1.13d  PDB: D:463-497          Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------Exon 1.7b  PDB: D:64-113 UniProt: 103-152         --------------------------------------------Exon 1.9b  PDB: D:158-215 UniProt: 197-254                ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.12d  PDB: D:424-463              ---------------------------------- Transcript 1 (2)
                 3gxd D   1 ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWHRQ 497
                                    10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180       190       200       210       220       230       240       250       260       270       280       290       300       310       320       330       340       350       360       370       380       390       400       410       420       430       440       450       460       470       480       490

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Classification and Annotation

SCOP Domains (2, 8)

CATH Domains (2, 8)

Pfam Domains (0, 0)

Gene Ontology (36, 36)

Asymmetric/Biological Unit(hide GO term definitions)

Chain A,B,C,D (GLCM_HUMAN | P04062)

molecular function
	GO:0004348	glucosylceramidase activity	Catalysis of the reaction: D-glucosyl-N-acylsphingosine + H2O = D-glucose + N-acylsphingosine.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0016798	hydrolase activity, acting on glycosyl bonds	Catalysis of the hydrolysis of any glycosyl bond.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0005102	receptor binding	Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
biological process
	GO:0005975	carbohydrate metabolic process	The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule.
	GO:0009267	cellular response to starvation	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
	GO:0071356	cellular response to tumor necrosis factor	Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
	GO:0046513	ceramide biosynthetic process	The chemical reactions and pathways resulting in the formation of ceramides, any N-acylated sphingoid.
	GO:0006680	glucosylceramide catabolic process	The chemical reactions and pathways resulting in the breakdown of glucosylceramides, any compound formed by the replacement of the glycosidic hydroxyl group of a cyclic form of glucose by a ceramide group.
	GO:0006687	glycosphingolipid metabolic process	The chemical reactions and pathways involving glycosphingolipids, any compound with residues of sphingoid and at least one monosaccharide.
	GO:0006629	lipid metabolic process	The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
	GO:0043407	negative regulation of MAP kinase activity	Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0032715	negative regulation of interleukin-6 production	Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
	GO:0016239	positive regulation of macroautophagy	Any process, such as recognition of nutrient depletion, that activates or increases the rate of macroautophagy to bring cytosolic macromolecules to the vacuole/lysosome for degradation.
	GO:0035307	positive regulation of protein dephosphorylation	Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.
	GO:1903052	positive regulation of proteolysis involved in cellular protein catabolic process	Any process that activates or increases the frequency, rate or extent of proteolysis involved in cellular protein catabolic process.
	GO:0016241	regulation of macroautophagy	Any process that modulates the frequency, rate or extent of macroautophagy.
	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	Any process that modulates the frequency, rate or extent of the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
	GO:0033561	regulation of water loss via skin	A process that modulates the rate or extent of water loss from an organism via the skin.
	GO:0043627	response to estrogen	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
	GO:0051384	response to glucocorticoid	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
	GO:0009268	response to pH	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus. pH is a measure of the acidity or basicity of an aqueous solution.
	GO:0033574	response to testosterone	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus.
	GO:0097066	response to thyroid hormone	A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thyroid hormone stimulus.
	GO:0043589	skin morphogenesis	The process in which the anatomical structures of the skin are generated and organized. The skin is the external membranous integument of an animal. In vertebrates the skin generally consists of two layers, an outer nonsensitive and nonvascular epidermis (cuticle or skarfskin) composed of cells which are constantly growing and multiplying in the deeper, and being thrown off in the superficial layers, as well as an inner, sensitive and vascular dermis (cutis, corium or true skin) composed mostly of connective tissue.
	GO:0006665	sphingolipid metabolic process	The chemical reactions and pathways involving sphingolipids, any of a class of lipids containing the long-chain amine diol sphingosine or a closely related base (a sphingoid).
	GO:0046512	sphingosine biosynthetic process	The chemical reactions and pathways resulting in the formation of sphingosine (sphing-4-enine), trans-D-erytho-2-amino-octadec-4-ene-1,3-diol, a long chain amino diol sphingoid base that occurs in most sphingolipids in animal tissues.
	GO:0023021	termination of signal transduction	The signaling process in which signal transduction is brought to an end rather than being reversibly modulated.
cellular component
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0043202	lysosomal lumen	The volume enclosed within the lysosomal membrane.
	GO:0005765	lysosomal membrane	The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
	GO:0005764	lysosome	A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 56)

Sites (56, 56)

SS Bonds (8, 8)

Cis Peptide Bonds (14, 14)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (156, 624)

PROSITE Motifs (0, 0)

Exons (9, 36)

Sequences/Alignments

Classification and Annotation

SCOP Domains (2, 8)

CATH Domains (2, 8)

Pfam Domains (0, 0)

Gene Ontology (36, 36)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File